Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Aflibercept vs. Ranibizumab: cost‐effectiveness of treatment for wet age‐related macular degeneration in Sweden
PaperCitations, authors & open-access status
Aflibercept vs. Ranibizumab: cost‐effectiveness of treatment for wet age‐related macular degeneration in Sweden is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 19 citations, 2016 year and bronze oa status.
19
Citations
2016
Year
bronze
OA Status